首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Human carbonic anhydrase XII: cDNA cloning expression and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers
【2h】

Human carbonic anhydrase XII: cDNA cloning expression and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers

机译:人类碳酸酐酶XII:在某些肾细胞癌中过表达的碳酸酐酶基因的cDNA克隆表达和染色体定位

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report the cloning and characterization of a tumor-associated carbonic anhydrase (CA) that was identified in a human renal cell carcinoma (RCC) by serological expression screening with autologous antibodies. The cDNA sequence predicts a 354-amino acid polypeptide with a molecular mass of 39,448 Da that has features of a type I membrane protein. The predicted sequence includes a 29-amino acid signal sequence, a 261-amino acid CA domain, an additional short extracellular segment, a 26-amino acid hydrophobic transmembrane domain, and a hydrophilic C-terminal cytoplasmic tail of 29 amino acids that contains two potential phosphorylation sites. The extracellular CA domain shows 30–42% homology with known human CAs, contains all three Zn-binding histidine residues found in active CAs, and contains two potential sites for asparagine glycosylation. When expressed in COS cells, the cDNA produced a 43- to 44-kDa protein in membranes that had around one-sixth the CA activity of membranes from COS cells transfected with the same vector expressing bovine CA IV. We have designated this human protein CA XII. Northern blot analysis of normal tissues demonstrated a 4.5-kb transcript only in kidney and intestine. However, in 10% of patients with RCC, the CA XII transcript was expressed at much higher levels in the RCC than in surrounding normal kidney tissue. The CA XII gene was mapped by using fluorescence in situ hybridization to 15q22. CA XII is the second catalytically active membrane CA reported to be overexpressed in certain cancers. Its relationship to oncogenesis and its potential as a clinically useful tumor marker clearly merit further investigation.
机译:我们报告了克隆和表征的肿瘤相关碳酸酐酶(CA)的人类肾细胞癌(RCC)中通过与自身抗体的血清学表达筛选确定的。 cDNA序列预测分子量为39,448 Da的354个氨基酸的多肽,具有I型膜蛋白的特征。预测的序列包括一个29个氨基酸的信号序列,一个261个氨基酸的CA结构域,一个额外的短细胞外区段,一个26个氨基酸的疏水跨膜结构域以及一个包含两个氨基酸的29个氨基酸的亲水性C末端胞质尾潜在的磷酸化位点。细胞外CA结构域与已知的人类CA具有30-42%的同源性,包含在活性CA中发现的所有三个与Zn结合的组氨酸残基,并且包含两个潜在的天冬酰胺糖基化位点。当在COS细胞中表达时,cDNA在膜上产生43-44kDa的蛋白质,该膜的CA活性约为用表达牛CA IV的相同载体转染的COS细胞膜的CA活性的六分之一。我们将这种人类蛋白命名为CA XII。正常组织的Northern印迹分析表明仅在肾脏和肠中有一个4.5-kb的转录本。但是,在10%的RCC患者中,CA XII转录本在RCC中的表达水平远高于周围正常肾脏组织。通过使用荧光原位杂交技术将CA XII基因定位到15q22。 CA XII是第二种催化活性膜CA,据报道在某些癌症中过表达。它与肿瘤发生的关系及其作为临床有用的肿瘤标志物的潜力显然值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号